Kraig Biocraft Laboratories (KBLB) 10-K 1 Apr 24 2023 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2023	Apr. 01, 2024	Jun. 30, 2023
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2023
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-56232
Entity Registrant Name	KRAIG BIOCRAFT LABORATORIES, INC.
Entity Central Index Key	0001413119
Entity Tax Identification Number	83-0459707
Entity Incorporation, State or Country Code	WY
Entity Address, Address Line One	2723 South State St. Suite 150
Entity Address, City or Town	Ann Arbor
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48104
City Area Code	(734)
Local Phone Number	619-8066
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 42,268,343
Entity Common Stock, Shares Outstanding		1,038,374,219
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Firm ID	2738
Auditor Name	M&K CPAS, PLLC
Auditor Location	The Woodlands, TX

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 2,551,834	$ 3,862,716
Inventory	6,884	6,580
Prepaid expenses	14,902	15,665
Deposit - Related Party		98,480
Total Current Assets	2,573,620	3,983,441
Property and Equipment, net	66,640	87,861
Investment in gold bullions (cost $450,216 and $450,216, respectively)	493,236	437,251
Operating lease right-of-use asset, net	95,808	58,849
Security deposit	3,518	3,518
Total Assets	3,232,822	4,570,920
Current Liabilities
Operating lease liability, current	41,789	39,200
Loan payable	35,244	95,244
Total Current Liabilities	8,885,610	8,072,083
Long Term Liabilities
Operating lease liability, net of current	54,368	20,697
Total Liabilities	8,939,978	8,092,780
Commitments and Contingencies (Note 9)
Stockholders’ Deficit
Preferred stock value
Common Stock Issuable, 1,122,311 and 1,122,311 shares, respectively	22,000	22,000
Additional paid-in capital	11,354,213	10,834,729
Accumulated Deficit	(49,686,780)	(46,657,000)
Total Stockholders’ Deficit	(5,707,156)	(3,521,860)
Total Liabilities and Stockholders’ Deficit	3,232,822	4,570,920
Series A Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock value	5,217,800	5,217,800
Common Class A [Member]
Stockholders’ Deficit
Common stock value	27,385,611	27,060,611
Common Class B [Member]
Stockholders’ Deficit
Common stock value
Nonrelated Party [Member]
Current Liabilities
Accounts payable and accrued expenses	541,637	540,339
Related Party [Member]
Current Liabilities
Accounts payable and accrued expenses	6,584,648	5,715,008
Note payable - related party	1,617,000	1,617,000
Royalty agreement payable - related party	$ 65,292	$ 65,292

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Investment owned, at cost
Preferred stock, no par value	$ 0	$ 0
Preferred stock, shares authorized	Unlimited	Unlimited
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock issuable	1,122,311	1,122,311
Series A Preferred Stock [Member]
Preferred stock, no par value	$ 0	$ 0
Preferred stock, shares issued	2	2
Preferred stock, shares outstanding	2	2
Common Class A [Member]
Common stock, no par value	$ 0	$ 0
Common stock, shares authorized	Unlimited	Unlimited
Common stock, shares issued	1,038,374,219	1,030,940,008
Common stock, shares outstanding	1,038,374,219	1,030,940,008
Common Class B [Member]
Common stock, no par value	$ 0	$ 0
Common stock, shares authorized	Unlimited	Unlimited
Common stock, shares issued	0	0
Common stock, shares outstanding	0	0
Investment in Gold [Member]
Investment owned, at cost	$ 450,216	$ 450,216

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue
Operating Expenses
General and Administrative	1,454,295	825,460
Professional Fees	125,222	339,710
Officer’s Salary	797,406	779,742
Research and Development	237,871	176,431
Total Operating Expenses	2,614,794	2,121,343
Loss from Operations	(2,614,794)	(2,121,343)
Other Income/(Expenses)
Net change in unrealized depreciation on investment in gold bullion	55,985	38
Interest expense	(484,658)	(609,129)
Amortization of debt issue costs		(1,111,580)
Asset impairment expense	(95,872)
Interest income	109,559
Total Other Income/(Expenses)	(414,986)	(1,720,671)
Net (Loss) before Provision for Income Taxes	(3,029,780)	(3,842,014)
Provision for Income Taxes
Net (Loss)	(3,029,780)	(3,842,014)
Other Comprehensive Income
Change in unrealized value of available-for-sale securities, net of income tax
Total Operating and Comprehensive Loss	$ (3,029,780)	$ (3,842,014)
Net Income (Loss) Per Share - Basic	$ 0	$ 0
Net Income (Loss) Per Share - Diluted	$ 0	$ 0
Weighted average number of shares outstanding during the period - Basic	1,033,122,597	974,307,366
Weighted average number of shares outstanding during the period - Diluted	1,033,122,597	974,307,366

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Deficit - USD ($)	Series A Preferred Stock [Member] Preferred Stock [Member]	Common Class A [Member] Common Stock [Member]	Common Class B [Member] Common Stock [Member]	Common Stock to be Issued [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Total
Balance at Dec. 31, 2021	$ 5,217,800	$ 22,385,132		$ 22,000	$ 9,894,179	$ (42,814,986)	$ (5,295,875)
Balance, shares at Dec. 31, 2021	2	927,378,166		1,122,311
Warrants issued for services - related parties					202,895		202,895
Warrants issued for services					31,803		31,803
Exercise of warrants in exchange for cash ($0.06/Sh and $0.08/Sh)		$ 739,864					739,864
Exercise of warrants in exchange for cash ($0.06/Sh and $0.08/Sh), shares		11,097,959
Convertible debt and accrued interest conversion into common stock ($0.0253/Sh-$0.06430/Sh)		$ 3,935,615					3,935,615
Convertible debt and accrued interest conversion into common stock ($0.0253/Sh-$0.06430/Sh), shares		92,463,883
Imputed interest - related party					80,849		80,849
Beneficial conversion feature					625,003		625,003
Net loss						(3,842,014)	(3,842,014)
Balance at Dec. 31, 2022	$ 5,217,800	$ 27,060,611		$ 22,000	10,834,729	(46,657,000)	(3,521,860)
Balance, shares at Dec. 31, 2022	2	1,030,940,008		1,122,311
Warrants issued for services					26,594		26,594
Imputed interest - related party					80,851		80,851
Net loss						(3,029,780)	(3,029,780)
Options issued for services - related parties					512,039		512,039
Shares issued for services		$ 225,000					225,000
Shares issued for services, shares		5,000,000
Shares issued in connection with cashless warrants exercise		$ 100,000			(100,000)
Shares issued in connection with cashless warrants exercise, shares		2,434,211
Balance at Dec. 31, 2023	$ 5,217,800	$ 27,385,611		$ 22,000	$ 11,354,213	$ (49,686,780)	$ (5,707,156)
Balance, shares at Dec. 31, 2023	2	1,038,374,219		1,122,311

Consolidated Statement of Cha_2

Consolidated Statement of Changes in Stockholders' Deficit (Parenthetical)	Dec. 31, 2022 $ / shares
Minimum [Member]
Warrant exercise price	$ 0.06
Conversion price per share	0.0253
Maximum [Member]
Warrant exercise price	0.08
Conversion price per share	$ 0.06430

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash Flows From Operating Activities:
Net Loss	$ (3,029,780)	$ (3,842,014)
Adjustments to reconcile net loss to net cash used in operations
Depreciation expense	27,620	28,103
Asset impairment expense	95,872
Net change in unrealized appreciation and depreciation in gold bullions	(55,985)	(38)
Amortization of debt discount		1,111,580
Imputed interest - related party	80,851	80,849
Stock issuable for services	225,000
Warrants issued/(cancelled) to consultants	538,633	234,698
Changes in operating assets and liabilities:
(Increase) in inventory	(304)	(6,580)
Decrease (Increase) prepaid expenses	763	(4,610)
Decrease (Increase) in deposits	2,608	(98,480)
Decrease in operating lease right-of-use, net	48,064	45,275
Increase in accrued expenses and other payables - related party	869,640	470,448
Decrease in accounts payable	1,298	138,159
Decrease in operating lease liabilities, current	(48,763)	(44,577)
Net Cash Used In Operating Activities	(1,244,483)	(1,887,187)
Net Cash Flows From Investing Activities
Purchase of treasury bills	(2,587,811)
Proceeds from maturity of treasury bills	2,587,811
Purchase of fixed assets	(6,399)	(5,021)
Net Cash Provided by Investing Activities	(6,399)	(5,021)
Cash Flows From Financing Activities:
Repayment of notes payable - related party		(40,000)
Proceeds from convertible note payable, net of original issue discount		2,760,000
Principal payments on debt	(60,000)	(60,000)
Proceeds from warrant exercise		739,864
Net Cash Used In Financing Activities	(60,000)	3,399,864
Net Change in Cash and Cash Equivalents	(1,310,882)	1,507,656
Cash and Cash Equivalents at Beginning of Year	3,862,716	2,355,060
Cash and Cash Equivalents at End of Year	2,551,834	3,862,716
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:
Shares issued in connection with cashless warrants exercise	100,000
Warrant discount in connection with cashless warrant exercise		625,003
Adoption of lease standard ASC 842	85,023
Shares issued in connection with convertible note payable		$ 3,935,615

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure [Table]
Net Income (Loss) Attributable to Parent	$ (3,029,780)	$ (3,842,014)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Insider Trading Arrangements [Line Items]
Rule 10b51 Arrangement Adopted	false
Non-Rule 10b51 Arrangement Adopted	false
Rule 10b51 Arrangement Terminated	false
Non-Rule 10b51 Arrangement Terminated	false

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION Organization Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. On March 5, 2018, the Company issued a board resolution authorizing investment in a Vietnamese subsidiary and appointing a representative for the subsidiary. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd Foreign Currency The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date. Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Cash and Cash Equivalents Cash and cash equivalents consist of demand deposits at financial institutions, money market funds, and highly liquid investments with original maturities of three months or less. As of December 31, 2023 and December 31, 2022, the Company had $ 2,551,834 3,862,716 Loss Per Share Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For December 31, 2023 and 2022, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive. The computation of basic and diluted loss per share for December 31, 2023 and December 31, 2022 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNING PER SHARE December 31, 2023 December 31, 2022 Stock Warrants (Exercise price - $ 0.001 0.25 67,335,714 54,660,032 Stock Options (Exercise price - $ 0.1150 26,520,000 26,520,000 Convertible Preferred Stock 2 2 Total 93,855,716 81,180,034 Investments During the year the Company had investments Treasury Bills. The Treasury Bills had remaining terms ranging from one month to three months on December 31, 2023. The Company classifies its investments in Treasury Bills as available-for-sale, accounted for at fair value with unrealized gains and losses recognized in other comprehensive gain on the statement of operations and comprehensive loss. During the year ended December 31, 2023, the Treasury Bills were redeemed, and the remaining balance is $ 0 The cost and estimated fair value of the Company’s investments are as follows: SCHEDULE OF COST AND ESTIMATED FAIR VALUE INVESTMENT Cost Gross unrealized gain Fair value December 31, 2022 $ - $ - $ - Treasury Bills $ 2,587,811 $ 13,021 $ 2,600,832 Treasury Bills – Redemption $ 2,587,811 $ (13,021 ) $ (2,600,832 ) Total Investments, December 31, 2023 $ - $ - $ - Research and Development Costs The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation. For the years ended December 31, 2023 and 2022, the Company had $ 237,871 176,431 Advertising Expense The Company follows the policy of charging the costs of advertising to expense as incurred. There was no Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) 2023 2022 Expected income tax (recovery) expense at the statutory rate of 21% $ (636,253 ) $ (806,823 ) Tax effect of expenses that are not deductible for income tax purposes (net of other amounts deductible for tax purposes) 180,647 282,808 Change in valuation allowance 455,606 524,014 Provision for income taxes $ - $ - The components of deferred income taxes are as follows: SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES 2023 2022 Years Ended December, 2023 2022 Deferred tax liability: $ - $ - Deferred tax asset Net Operating Loss Carryforward 5,342,957 4,887,351 Valuation allowance (5,342,957 ) (4,887,351 ) Net deferred tax asset - - Net deferred tax liability $ - $ - The valuation allowance was established to reduce the deferred tax asset to the amount that will more likely than not be realized. This is necessary due to the Company’s continued operating losses and the uncertainty of the Company’s ability to utilize all of the net operating loss carryforwards before they will expire through the year 2042. The net change in the valuation allowance for the year ended December 31, 2023 and 2022 was an increase of $ 455,606 524,014 Stock-Based Compensation The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07. RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS In March 2022, the Financial Accounting Standards Board (the “FASB”) issued ASU 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (“ASU 2022-02”), which eliminates the accounting guidance on troubled debt restructurings (“TDRs”) for creditors in ASC 310, Receivables (Topic 310), and requires entities to provide disclosures about current period gross write-offs by year of origination. Also, ASU 2022-02 updates the requirements related to accounting for credit losses under ASC 326, Financial Instruments – Credit Losses (Topic 326), and adds enhanced disclosures for creditors with respect to loan refinancings and restructurings for borrowers experiencing financial difficulty. ASU 2022-02 was effective for the Company January 1, 2023. The adoption of ASU 2022-02 did not have a material impact on the Company’s consolidated financial statements. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Changes to accounting principles are established by the FASB in the form of Accounting Standards Updates (“ASU’s”) to the FASB’s Codification. We consider the applicability and impact of all ASU’s on our consolidated financial position, results of operations, stockholders’ equity, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements issued through the date these financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective accounting pronouncements, when adopted, will have a material impact on the consolidated financial statements of the Company. This guidance was adopted on January 1, 2023. The adoption of ASU 2022-02 did not have a material impact on the Company’s consolidated financial statements. There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on our consolidated financial position, results of operations or cash flows. Equipment The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. In accordance with FASB ASC No. 360, Property, Plant and Equipment, Fair Value of Financial Instruments We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” The three levels of the fair value hierarchy under ASC Topic 820-10 are described below: ● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at December 31, 2023 and 2022. ● Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. ● Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms. The following are the major categories of assets measured at fair value on a recurring basis: as of December 31, 2023 and December 31, 2022, using quoted prices in active markets for identical liabilities (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3): The Company has consistently applied the valuation techniques in all periods presented. The following table presents the Company’s assets which were measured at fair value at December 31, 2023 and December 31, 2022: SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS December 31, 2023 December 31, 2022 Fair Value Measurement Using Fair Value Measurement Using Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets: Investment in gold $ 493,236 $ - $ - $ 493,236 $ 437,251 $ - $ - $ 437,251 Money market fund $ 2,409,486 $ - $ - $ 2,409,486 $ - $ - $ - $ - Total $ 2,902,722 $ - $ - $ 2,902,722 $ 437,251 $ - $ - $ 437,251 The Board of Directors, who serves as the Custodian, is responsible for the safekeeping of gold bullion owned by the Company. Fair value of the gold bullion held by the Company is based on that day’s London Bullion Market Association (“LBMA”) Gold Price PM. “LBMA Gold Price PM” is the price per fine troy ounce of gold, stated in U.S. dollars, determined by ICE Benchmark Administration (“IBA”) following an electronic auction consisting of one or more 30-second rounds starting at 3:00 p.m. (London time), on each day that the London gold market is open for business and published shortly thereafter. The fair value of the treasury bills is based on quoted market prices in an active market. The Company has determined the fair value based on financial factors that are considered level 1 inputs in the fair value hierarchy. Money market funds included in cash and cash equivalents and U.S. government-backed securities are measured at fair value based on quoted prices in active markets, which are considered Level 1 inputs. The Company’s policy is to recognize transfers in and/or out of the fair value hierarchy as of the date in which the event or change in circumstances caused the transfer. The following tables summarize activity in gold bullion for the quarter ended December 31, 2023: SCHEDULE OF GOLD IN BULLION Year Ended December 31, 2023 Ounces Cost Fair Value Balance December 31, 2021 239 $ 1,884 $ 437,212 Net change in unrealized gain - 38 38 Balance December 31, 2022 239 $ 1,829 $ 437,251 Net change in unrealized gain - 235 55,985 Balance December 31, 2023 239 $ 2,064 $ 493,236 Revenue Recognition Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the years ended December 31, 2023 and 2022, the Company recognized $ 0 0 Concentration of Credit Risk The Company at times has cash and cash equivalents in banks in excess of FDIC insurance limits. At December 31, 2023 and December 31, 2022, the Company had approximately $ 2,409,486 3,285,197 On March 12, 2023, the U.S. government took extraordinary steps to stop a potential banking crisis after the historic failure of Silicon Valley Bank, assuring all depositors at the failed institution that they could access all their money quickly, even as another major bank was shut down. The Company had no exposure to a failed bank. The Company averts risks associated with such a crisis by holding minimum cash balances required for uninterrupted operations, federal funds money market fund, and U.S. government-backed securities. As of December 31, 2023, the Company held $ 2,409,486 1. 99.5 Original Issue Discount For certain notes issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded as a debt discount, reducing the face amount of the note, and is amortized to amortization of original issue discount in the consolidated statements of operations over the life of the debt. Debt Issue Cost Debt issuance cost paid to lenders, or third parties are recorded as debt discounts and amortized to interest expense in the consolidated statements of operations, over the life of the underlying debt instrument. Deposit– Related Party During the year ended December 31, 2022, the Company paid $ 98,480 15% 95,872 0 The Company recognized an impairment expense of $ 95,872 0 Investments without a Readily Determinable Fair Value (Cost Method) Investments in nonmarketable entities in which the Company is not able to exercise significant influence, our “Cost Method Investments,” are accounted for at our initial cost, minus any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company holds a 15 0

GOING CONCERN

GOING CONCERN	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 GOING CONCERN As reflected in the accompanying financial statements, the Company has a working capital deficiency of $ 6,311,990 5,707,156 1,244,483 Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

EQUIPMENT

EQUIPMENT	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
EQUIPMENT	NOTE 3 EQUIPMENT At December 31, 2023 and December 31, 2022, property and equipment, net, is as follows: SCHEDULE OF PROPERTY AND EQUIPMENT December 31, 2023 December 31, 2022 Estimated Useful Lives (Years) Automobile $ 41,805 $ 41,805 5 Laboratory Equipment 130,310 123,911 5 10 Office Equipment 7,260 7,260 5 10 Leasehold Improvements 82,739 82,739 2 5 Less: Accumulated Depreciation (195,474 ) (167,854 ) Total Property and Equipment, net $ 66,640 $ 87,861 Depreciation expense for the years ended December 31, 2023 and 2022, was $ 27,620 28,103

RIGHT TO USE ASSETS AND LEASE L

RIGHT TO USE ASSETS AND LEASE LIABILITY	12 Months Ended
	Dec. 31, 2023
Right To Use Assets And Lease Liability
RIGHT TO USE ASSETS AND LEASE LIABILITY	NOTE 4 - RIGHT TO USE ASSETS AND LEASE LIABILITY We determine if an arrangement is a lease, or contains a lease, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. We have a lease agreement with lease and non-lease components and have elected to utilize the practical expedient to account for lease and non-lease components together as a single combined lease component, from both a lessee and lessor perspective with the exception of direct sales-type leases and production equipment classes embedded in supply agreements. From a lessor perspective, the timing and pattern of transfer are the same for the non-lease components and associated lease component and, the lease component, if accounted for separately, would be classified as an operating lease. We have elected not to present short-term leases on the balance sheet as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that we are reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because our lease does not provide an implicit rate of return, we used our incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments. In general, leases, where we are the lessee, may include options to extend the lease term. These leases may include options to terminate the lease prior to the end of the agreed upon lease term. For purposes of calculating lease liabilities, lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. Lease expense for operating leases is recognized on a straight-line basis over the lease term as cost of revenues or operating expenses depending on the nature of the leased asset. Certain operating leases provide for annual increases to lease payments based on an index or rate. We calculate the present value of future lease payments based on the index or rate at the lease commencement date. Differences between the calculated lease payment and actual payment are expensed as incurred. Amortization of finance lease assets is recognized over the lease term as cost of revenues or operating expenses depending on the nature of the leased asset. Interest expense on finance lease liabilities is recognized over the lease term in interest expense. Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $ 2,508 On September 5, 2019, we signed a two 5,000 42,000 44,800 42,000 44,800 79,862 79,862 44,800 47,600 85,022 85,022 5 4,560.57 45,150 5 241,800 On July 1, 2021, the Company signed a 5 6,000 8,645 The tables below present information regarding the Company’s operating lease assets and liabilities at December 31, 2023; At December 31, 2023 and December 31, 2022, the Company had no financing leases as defined in ASC 842, “Leases.” SCHEDULE OF OPERATING LEASES December 31, 2023 December 31, 2022 Assets Operating lease - right-of-use asset - non-current $ 95,808 $ 58,849 Liabilities Operating lease liability $ 96,157 $ 59,897 Weighted-average remaining lease term (three months) 1.95 2.08 Weighted-average discount rate 8 % 8 % The components of lease expense were as follows: Operating lease costs Amortization of right-of-use operating lease asset $ 20,194 $ 52,043 Total operating lease costs $ 20,194 $ 52,043 Supplemental cash flow information related to operating leases was as follows: Operating cash outflows from operating lease (obligation payment) $ 53,442 $ 51,344 Right-of-use asset obtained in exchange for new operating lease liability $ - $ - Future minimum lease payments required under leases that have initial or remaining non-cancelable lease terms in excess of one year at December 31, 2023: SCHEDULE OF MINIMUM LEASE PAYMENTS 2024 $ 54,144 2025 44,344 2026 5,764 Total lease payments 104,252 Less: amount representing interest (8,095 ) Total lease obligations 96,157 Less: current portion of operating lease liability (41,789 ) Long-term portion operating lease liability $ 54,368

NOTE PAYABLE _ RELATED PARTY

NOTE PAYABLE – RELATED PARTY	12 Months Ended
	Dec. 31, 2023
Note Payable Related Party
NOTE PAYABLE – RELATED PARTY	NOTE 5 NOTE PAYABLE – RELATED PARTY Between June 6, 2016, and December 1, 2020 the Company received a total of $ 1,657,000 3 On January 26, 2022, the Company repaid $ 40,000 Total loan payable to the founder and CEO for as of December 31, 2023 is $ 1,617,000 Total loan payable to the founder and CEO as of December 31, 2022 is $ 1,617,000 During the year ended December 31, 2023, the Company recorded $ 80,851 56,050 246,714 During the year ended December 31, 2022, the Company recorded $ 80,849 54,755 107,882

LOAN PAYABLE

LOAN PAYABLE	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
LOAN PAYABLE	NOTE 6 LOAN PAYABLE On March 1, 2019, the Company entered into an unsecured promissory note with Notre Dame - an unrelated party in the amount of $ 265,244 10 1. $ 1,000 2. $ 2,000 3. $ 5,000 4. Final payment of all remaining balance, in the amount of $ 180,224 On July 8, 2021, the Company entered into an amendment to the March 1, 2019 agreement. As of the date of the amendment, the remaining outstanding balance was $ 180,244 1. $ 5,000 2. Final payment of the remaining balance in the amount of $ 115,244 57,622 57,622 The Company has continued to make $ 5,000 During the year ended December 31, 2023, the Company paid $ 60,000 35,244

CONVERTIBLE NOTES

CONVERTIBLE NOTES	12 Months Ended
	Dec. 31, 2023
Convertible Notes
CONVERTIBLE NOTES	NOTE 7 CONVERTIBLE NOTES On December 11, 2020, the Company issued 3,125,000 5 2,599,066 SCHEDULE OF FAIR VALUE WARRANTS Stock Price $ 0.14 Exercise price $ 0.16 Expected term (in years) 5 Expected volatility 60.64 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.10 % The Company has determined that ASC 815 does not apply since the Company has unlimited authorized shares, which in turn satisfies the requirement of having sufficient authorized shares available to settle any potential instruments that may require physical net-share settlement. Pursuant to ASC 470, the Company will record a beneficial conversion feature (“BCF”) based upon the relative fair value of the conversion feature within the convertible note and the related warrants. The BCF cannot exceed the face amount of the note, therefore, the discount for this note is $ 1,000,000 The Company also paid $ 86,000 On March 25, 2021, the Company entered into one year 4,000,000 500,000 10 The note contained a discount to market feature, whereby, the lender could purchase stock at 80% of the lowest trading price for a period of ten (10) days preceding the conversion date. 500,000 3,000,000 Additionally, the Company issued 8,000,000 5 3,359,716 Stock Price $ 0.15 Exercise price $ 0.25 Expected term (in years) 5 Expected volatility 100.76 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.07 % The Company has determined that ASC 815 does not apply since the Company has unlimited authorized shares, which in turn satisfies the requirement of having sufficient authorized shares available to settle any potential instruments that may require physical net-share settlement. Pursuant to ASC 470, the Company will record a beneficial conversion feature (“BCF”) based upon the relative fair value of the conversion feature within the convertible note and the related warrants. The BCF cannot exceed the face amount of the note, therefore, the discount for this note is $ 3,670,000 The Company also paid $ 330,000 On January 21, 2022, the Company issued 3,935,417 250,000 2,260 On January 31, 2022, the Company issued 4,569,059 250,000 42,877 On February 16, 2022, the Company issued 3,924,443 250,000 1,164 The Company issued a $ 1,500,000 thirteen-month February 18, 2023 10 10,000 1,490,000 The note contained a discount to market feature, whereby, the lender could purchase stock at 85% of the lowest trading price for a period of ten (10) days preceding the conversion date. As of October 26, 2022 this debenture was satisfied. Additionally, the Company issued 12,000,000 5 0.12 4,285,714 0.14 1,071,437 Stock Price $ 0.08 Exercise price $ 0.12 0.14 Expected term (in years) 5 Expected volatility 124.10 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.58 % The Company has determined that ASC 815 does not apply since the Company has unlimited authorized shares, which in turn satisfies the requirement of having sufficient authorized shares available to settle any potential instruments that may require physical net-share settlement. In connection with $ 1,500,000 16,785,714 625,003 The Company also paid $ 115,000 On April 14, 2022, the Company issued 2,358,380 150,000 1,644 On April 29, 2022, the Company issued 4,272,417 250,000 5,918 On May 17, 2022, the Company issued 3,628,325 200,000 5,726 On June 6, 2022, the Company issued 3,549,793 200,000 5,178 On June 14, 2022, the Company issued 2,902,922 100,000 60,822 On June 21, 2022, the Company issued 3,393,979 150,000 3,068 On June 30, 2022, the Company issued 3,401,877 150,000 3,425 On July 19, 2022, the Company issued 4,364,987 200,000 6,027 On August 18, 2022, the Company issued 4,325,913 200,000 7,644 On September 8, 2022, the Company issued 3,396,898 150,000 4,219 On September 26, 2022, the Company issued 3,605,259 150,000 2,863 On October 11, 2022, the Company issued 2,907,240 100,000 1,753 On October 18, 2022, the Company issued 4,782,778 150,000 658 On October 26, 2022, the Company issued 5,487,951 150,000 370 On October 31, 2022, the Company issued 6,510,348 150,000 28,384 On November 1, 2022, the Company issued 9,236,212 250,000 301 On November 14, 2022, the Company issued 5,974,335 150,000 1,151 On November 17, 2022, the Company issued 5,935,350 150,000 164 The Company issued a $ 1,500,000 thirteen-month May 11, 2023 10 The note contained a discount to market feature, whereby, the lender could purchase stock at 85% of the lowest trading price for a period of ten (10) days preceding the conversion date. As of November 17, 2022 this debenture was satisfied. The Company also paid $ 115,000 As of November 17, 2022, the above three notes were fully converted, with the no remaining balance due. The following represents a summary of the Company’s convertible debt at December 31, 2023: SUMMARY OF CONVERTIBLE DEBT Convertible Note Payable Amounts Balance – December 31, 2021 $ 503,423 Proceeds 3,000,000 Debt discount and issue costs recorded (865,000 ) Conversion of debt into common shares (3,750,003 ) Amortization of debt discount 1,111,580 Balance – December 31, 2022 $ - No activity – December 31, 2023 - Balance – December 31, 2023 $ - Accrued Interest Payable Amounts Balance – December 31, 2021 31,657 Interest Expense December 31, 2022 153,955 Interest conversion into common shares (185,612 ) Balance – December 31, 2022 $ - No activity – December 31, 2023 - Balance – December 31, 2023 $ -

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 8 STOCKHOLDERS’ DEFICIT (A) Common Stock Issued for Cash On March 9, 2019, the Company entered into a purchase agreement with one investor (the “Purchase Agreement”). Pursuant to the Purchase Agreement, the Company issued the investor 14,797,278 0.06758 1,000,000 14,797,278 14,797,278 0.06 7,398,639 0.08 ● ½ of all $ 0.06 March 8, 2021 ● ½ of all $ 0.06 March 8, 2022 ● ½ of all $ 0.08 March 8, 2022 ● ½ of all $ 0.08 March 8, 2023 All unexercised warrants are now expired. On February 15, 2022, the Company issued 7,398,639 7,398,639 443,918 On February 15, 2022, the Company issued 3,699,320 3,699,320 295,946 (B) Common Stock Issued for Services Shares issued for services as mentioned below were valued at the closing price of the stock on the date of grant. On December 26, 2023, the Company issued 5,000,000 225,000 0.045 (C) Common Stock Warrants and Options On February 16, 2023, the Company issued 2,434,211 2,500,000 On February 15, 2022, the Company issued 7,398,639 7,398,639 443,918 On February 15, 2022, the Company issued 3,699,320 3,699,320 295,946 On April 11, 2022, the Company extended the expiration date of the warrant issued on May 28, 2015 to May 27, 2025. No additional expense was recorded due to rate difference being de minimis. On December 13, 2023 the Company issued a 10-year option to purchase 10,00,000 0.04 260,000 260,000 SCHEDULE OF OPTION ASSUMPTION Expected dividends 0 % Expected volatility 133.30 % Expected term 5 Risk free interest rate 4.00 % Expected forfeitures 0 % On December 13, 2023, the Company issued a 5-year option to purchase 6,000,000 0.04 162,000 Options vest 20% on the grant date, 20% will vest on the second anniversary, 20% will vest on the third-year anniversary, 20% will vest on the fourth year anniversary as long as the employee remains with the Company at the end of each successive year for four years. Options will be exercisable on December 31, 2023, and for a period of 10 years expiring on December 13, 2033. 32,400 Expected dividends 0 % Expected volatility 133.30 % Expected term 6.25 Risk free interest rate 4.04 % Expected forfeitures 0 % On December 13, 2023, the Company issued a 5-year option to purchase 4,000,000 0.04 108,000 Options vest 20% on the grant date, 20% will vest on the second anniversary, 20% will vest on the third-year anniversary, 20% will vest on the fourth year anniversary as long as the employee remains with the Company at the end of each successive year for four years. Options will be exercisable on December 31, 2023, and for a period of 10 years expiring on December 13, 2033. 21,600 Expected dividends 0 % Expected volatility 133.30 % Expected term 6.25 Risk free interest rate 4.04 % Expected forfeitures 0 % On January 25, 2021, the Company issued a 7-year option to purchase 2,500,000 0.134 310,165 Options vest 33.3% on the year one anniversary of the grant date, 33.3% will vest on the second anniversary, and 33.3% will vest on the third year anniversary as long as the employee remains with the Company at the end of each successive year for three years. Options will be exercisable on January 25, 2021, and for a period of 7 years expiring on January 25, 2028. 93,752 Expected dividends 0 % Expected volatility 133.22 % Expected term 7 Risk free interest rate 1.46 % Expected forfeitures 0 % On February 19, 2020 the Company issued a 10-year option to purchase 6,000,000 0.115 626,047 Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030. 104,270 Expected dividends 0 % Expected volatility 125.19 % Expected term 3 Risk free interest rate 1.50 % Expected forfeitures 0 % On February 19, 2020 the Company issued a 7-year option to purchase 1,340,000 0.115 133,063 Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027. 26,594 Expected dividends 0 % Expected volatility 125.19 % Expected term 6 Risk free interest rate 1.46 % Expected forfeitures 0 % Warrant activity as of December 31, 2023 is summarized as follows: SCHEDULE OF WARRANTS ACTIVITY Warrants Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding - December 31, 2021 48,972,279 $ 0.12 2.64 $ 1,248,452 Exercisable - December 31, 2021 48,972,279 $ 0.12 2.64 $ 1,248,452 Granted 16,785,714 $ 0.12 4.05 - Exercised (11,097,959 ) $ 0.07 - - Cancelled/Forfeited - $ - - - Outstanding - December 31, 2022 54,660,034 $ 0.13 3.04 $ 319,000 Exercisable - December 31, 2022 54,660,034 $ 0.13 3.04 $ 319,000 Granted 20,000,000 $ 0.04 8.96 - Exercised (2,500,000 ) $ 0.001 - - Cancelled/Forfeited (4,824,320 ) $ 0.11 - - Outstanding – December 31, 2023 67,335,714 $ 0.12 3.89 $ 331,500 Exercisable – December 31, 2023 67,335,714 $ 0.12 3.89 $ 331,500 As of December 31, 2023, the following warrants were outstanding: SCHEDULE OF WARRANTS OUTSTANDING Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate Intrinsic Value $ 0.001 8,500,000 2.14 $ 331,500 $ 0.04 2,300,000 2.75 $ - $ 0.056 1,000,000 1.52 $ - $ 0.2299 7,125,000 1.27 $ - $ 0.16 3,125,000 1.95 $ - $ 0.25 8,000,000 2.23 $ - $ 0.1160 500,000 1.52 $ - $ 0.12 12,500,000 3.05 $ - $ 0.14 4,285,714 3.05 $ - $ 0.04 4,000,000 9.95 $ - $ 0.04 6,000,000 9.95 $ - $ 0.04 10,000,000 9.95 $ - 67,335,714 $ 331,500 For the year ended December 31, 2022, the following warrants were outstanding: Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate Intrinsic Value $ 0.001 11,000,000 3.43 $ 321,000 $ 0.04 2,300,000 3.75 $ - $ 0.056 1,000,000 2.02 $ - $ 0.08 3,699,320 0.18 $ - $ 0.2299 8,250,000 2.21 $ - $ 0.16 3,125,000 2.95 $ - $ 0.25 8,000,000 3.23 $ - $ 0.1160 500,000 2.52 $ - $ 0.12 12,500,000 4.05 $ - $ 0.14 4,285,714 4.05 $ - 54,660,034 $ 321,000 Options activity as of December 31, 2023 is summarized as follows: SCHEDULE OF OPTIONS ACTIVITY Options Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding - December 31, 2021 26,802,500 $ 0.12 19.12 $ - Exercisable - December 31, 2021 26,802,500 $ 0.12 19.12 $ - Granted - $ - - - Exercised - $ - - - Cancelled/Forfeited (282,500 ) $ 0.12 5.00 - Outstanding - December 31, 2022 26,520,000 $ 0.12 18.27 $ - Granted - $ - - - Exercised - $ - - - Cancelled/Forfeited - $ - - - Outstanding – December 31, 2023 26,520,000 $ 0.12 17.27 $ - Exercisable – December 31, 2023 26,520,000 $ 0.12 17.27 $ - For the year ended December 31, 2023, the following options were outstanding: SCHEDULE OF OPTIONS OUTSTANDING Exercise Price Options Outstanding Options Exercisable Weighted Average Remaining Contractual Life (in Years) $ 0.115 26,520,000 26,520,000 17.27 For the year ended December 31, 2022, the following options were outstanding: Exercise Price Options Outstanding Options Exercisable Weighted Average Remaining Contractual Life (in Years) $ 0.115 26,520,000 26,520,000 18.52 (C) Amendment to Articles of Incorporation On February 16, 2009, the Company amended its articles of incorporation to amend the number and class of shares the Company is authorized to issue as follows: ● Common stock Class A, unlimited no ● Common stock Class B, unlimited no ● Preferred stock, unlimited no Effective December 17, 2013, the Company amended its articles of incorporation to designate a Series A no Two (D) Common Stock Issued for Debt As of November 17, 2022, the Company has satisfied all debentures to Yorkville Advisors. On November 17, 2022, the Company issued 5,935,350 150,000 164 On November 14, 2022, the Company issued 5,974,335 150,000 1,151 On November 1, 2022, the Company issued 9,236,212 250,000 301 On October 31, 2022, the Company issued 6,510,348 150,000 28,384 On October 26, 2022, the Company issued 5,487,951 150,000 370 On October 18, 2022, the Company issued 4,782,778 150,000 658 On October 11, 2022, the Company issued 2,907,240 100,000 1,753 On September 26, 2022, the Company issued 3,605,259 150,000 2,863 On September 8, 2022, the Company issued 3,396,898 150,000 4,219 On August 18, 2022, the Company issued 4,325,913 200,000 7,644 On July 19, 2022, the Company issued 4,364,987 200,000 6,027 On June 30, 2022, the Company issued 3,401,877 150,000 3,425 On June 21, 2022, the Company issued 3,393,979 150,000 3,068 On June 14, 2022, the Company issued 2,902,922 100,000 60,822 On June 6, 2022, the Company issued 3,549,793 200,000 5,178 On May 17, 2022, the Company issued 3,628,325 200,000 5,726 On April 14, 2022, the Company issued 2,358,380 150,000 1,644 On April 29, 2022, the Company issued 4,272,417 250,000 5,918 On February 16, 2022, the Company issued 3,924,443 250,000 1,164 On January 21, 2022, the Company issued 3,935,417 250,000 2,260 On January 31, 2022, the Company issued 4,569,059 250,000 42,877

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 9 COMMITMENTS AND CONTINGENCIES On November 10, 2010, the Company entered into an employment agreement with its CEO, effective January 1, 2011 through the December 31, 2015. The term of the agreement is a five year 210,000 6 281,027 20 5 297,889 5 315,764 5 447,915 3,511,776 3,077,393 On January 20, 2015, the board of directors appointed Mr. Jonathan R. Rice as our Chief Operating Officer. Mr. Rice’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to an annual cash compensation of $ 120,000 11,000 three 2,000,000 0.001 three 3,000,000 0.001 May 28, 2022 121,448 140,000 6,000,000 0.001 May 20, 2026 five 6,000,000 0.2299 20,000 20,000 20,000 As of December 31, 2023 and December 31, 2022, the Company owes $ 3,482 3,728 On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to annual cash compensation of $ 60,000 three 2,000,000 0.2299 1,154 1,243 Legal Matters The Company may be involved in legal actions and claims arising in the ordinary course of business, from time to time, none of which at the time are considered to be material to the Company’s business or financial condition. (A) License Agreement On May 8, 2006, the Company entered into a license agreement. Pursuant to the terms of the agreement, the Company paid a non- refundable license fee of $ 10,000 10,000 13,700 10,000 On October 28, 2011, the Company entered into a license agreement with the University of Notre Dame. Under the agreement, the Company received exclusive and non-exclusive rights to certain spider silk technologies including commercial rights with the right to sublicense such intellectual property. In consideration of the licenses granted under the agreement, the Company agreed to issue to the University of Notre Dame 2,200,000 2 20 The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $ 5,000 265,244 4,025,652 281,659 60,000 On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. In accordance with FASB ASC No 480, Distinguishing Liabilities from Equity, 120,000 65,292 1,960 (B) Operating Lease Agreements Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $ 2,508 for conference facilities, mail, fax, and reception services located at our principal place of business. On July 1, 2021, the Company signed a 5 year property lease in Vietnam which consists of 6,000 square meters of space, which it leases at a current rent of approximately $ 8,645 per year. The Company accounts for the lease in accordance with ASC Topic 842, “Leases” On September 13, 2017, the Company signed a two year lease with a 2 year option commencing on October 1, 2017 and ending on September 31, 2019. The Company paid an annual rent of $ 39,200 42,000 the Company signed a new two-year lease for this 5,000 square foot property in Lansing, MI that commenced on October 1, 2019 and ended on September 30, 2021, for its research and development headquarters. 42,000 44,800 42,000 44,800 44,800 47,600 Leases

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 10 RELATED PARTY TRANSACTIONS Accounts payable and accrued expenses – related party consists of the following: SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES RELATED PARTY As of As of Accounts payable - related party $ 388,001 $ 356,191 Accrued expenses - related party 3,516,411 3,082,363 Accrued interest - related party 2,680,236 2,276,454 Total accounts payable and accrued expenses - related party $ 6,584,648 $ 5,715,008 Between June 6, 2016, and December 1, 2020 the Company received a total of $ 1,657,000 3 On January 26, 2022, the Company repaid $ 40,000 Total loan payable to principal stockholder for as of December 31, 2023 is $ 1,617,000 Total loan payable to this principal stockholder as of December 31, 2022 is $ 1,617,000 During the year ended December 31, 2023, the Company recorded $ 80,851 56,050 246,714 During the year ended December 31, 2022, the Company recorded $ 80,849 54,755 107,882 As of December 31, 2023, and December 31, 2022, there was $ 388,001 356,191 As of December 31, 2023, and December 31, 2022, there was $ 3,516,411 3,082,363 As of December 31, 2023, and December 31, 2022, there was $ 2,680,236 2,276,454 In aggregate as of December 31, 2023, and December 31, 2022, the Company owed $ 6,584,648 5,715,008 As of December 31, 2023 and December 31, 2022, the Company owed $ 65,292 65,292 During the year ended December 31, 2022, the Company paid $ 98,480 15 95,872 0

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11 SUBSEQUENT EVENTS The Company has analyzed its operations subsequent to April 1, 2024 through the date these financial statements were issued, and other than those listed below, has determined that it does not have any material subsequent events to disclose. On January 24, 2024, the Company signed a memorandum of understand with the Vietnam Sericulture Association (“VSA”) and the Lam Dong Agro-Forestry Research & Experiment Center (“LAREC”) to enhance sericulture in Vietnam through the expanded application of the Company’s spider silk silkworm technology. On January 31, 2024, the Company signed a five -year lease for a 700 square meter facility in Lam Dong, Vietnam that commenced on February 1, 2024 and ends on January 31, 2029. We pay an annual rent of ~$ 7,284 for year one and two of the lease. For years 3-5 the price will increase with Vietnam’s state land price bracket, not to exceed 10%. On February 2, 2024, the Company repaid $ 90,000 On March 26, 2024, the Company authorized the reclassification of two shares of Preferred stock into Series A preferred stock as approved by the board of directors. On March 26, 2024, the Company issued one share of Series A preferred stock to Mr. Thompson, our CEO and founder. In consideration for the share of Series A preferred stock, Mr. Thompson paid twenty thousand dollars ($ 20,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Policies)	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. On March 5, 2018, the Company issued a board resolution authorizing investment in a Vietnamese subsidiary and appointing a representative for the subsidiary. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd
Foreign Currency	Foreign Currency The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date.
Use of Estimates	Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of demand deposits at financial institutions, money market funds, and highly liquid investments with original maturities of three months or less. As of December 31, 2023 and December 31, 2022, the Company had $ 2,551,834 3,862,716
Loss Per Share	Loss Per Share Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For December 31, 2023 and 2022, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive. The computation of basic and diluted loss per share for December 31, 2023 and December 31, 2022 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNING PER SHARE December 31, 2023 December 31, 2022 Stock Warrants (Exercise price - $ 0.001 0.25 67,335,714 54,660,032 Stock Options (Exercise price - $ 0.1150 26,520,000 26,520,000 Convertible Preferred Stock 2 2 Total 93,855,716 81,180,034
Investments	Investments During the year the Company had investments Treasury Bills. The Treasury Bills had remaining terms ranging from one month to three months on December 31, 2023. The Company classifies its investments in Treasury Bills as available-for-sale, accounted for at fair value with unrealized gains and losses recognized in other comprehensive gain on the statement of operations and comprehensive loss. During the year ended December 31, 2023, the Treasury Bills were redeemed, and the remaining balance is $ 0 The cost and estimated fair value of the Company’s investments are as follows: SCHEDULE OF COST AND ESTIMATED FAIR VALUE INVESTMENT Cost Gross unrealized gain Fair value December 31, 2022 $ - $ - $ - Treasury Bills $ 2,587,811 $ 13,021 $ 2,600,832 Treasury Bills – Redemption $ 2,587,811 $ (13,021 ) $ (2,600,832 ) Total Investments, December 31, 2023 $ - $ - $ -
Research and Development Costs	Research and Development Costs The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation. For the years ended December 31, 2023 and 2022, the Company had $ 237,871 176,431
Advertising Expense	Advertising Expense The Company follows the policy of charging the costs of advertising to expense as incurred. There was no
Income Taxes	Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) 2023 2022 Expected income tax (recovery) expense at the statutory rate of 21% $ (636,253 ) $ (806,823 ) Tax effect of expenses that are not deductible for income tax purposes (net of other amounts deductible for tax purposes) 180,647 282,808 Change in valuation allowance 455,606 524,014 Provision for income taxes $ - $ - The components of deferred income taxes are as follows: SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES 2023 2022 Years Ended December, 2023 2022 Deferred tax liability: $ - $ - Deferred tax asset Net Operating Loss Carryforward 5,342,957 4,887,351 Valuation allowance (5,342,957 ) (4,887,351 ) Net deferred tax asset - - Net deferred tax liability $ - $ - The valuation allowance was established to reduce the deferred tax asset to the amount that will more likely than not be realized. This is necessary due to the Company’s continued operating losses and the uncertainty of the Company’s ability to utilize all of the net operating loss carryforwards before they will expire through the year 2042. The net change in the valuation allowance for the year ended December 31, 2023 and 2022 was an increase of $ 455,606 524,014
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07.
RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS	RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS In March 2022, the Financial Accounting Standards Board (the “FASB”) issued ASU 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (“ASU 2022-02”), which eliminates the accounting guidance on troubled debt restructurings (“TDRs”) for creditors in ASC 310, Receivables (Topic 310), and requires entities to provide disclosures about current period gross write-offs by year of origination. Also, ASU 2022-02 updates the requirements related to accounting for credit losses under ASC 326, Financial Instruments – Credit Losses (Topic 326), and adds enhanced disclosures for creditors with respect to loan refinancings and restructurings for borrowers experiencing financial difficulty. ASU 2022-02 was effective for the Company January 1, 2023. The adoption of ASU 2022-02 did not have a material impact on the Company’s consolidated financial statements.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS	RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Changes to accounting principles are established by the FASB in the form of Accounting Standards Updates (“ASU’s”) to the FASB’s Codification. We consider the applicability and impact of all ASU’s on our consolidated financial position, results of operations, stockholders’ equity, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements issued through the date these financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective accounting pronouncements, when adopted, will have a material impact on the consolidated financial statements of the Company. This guidance was adopted on January 1, 2023. The adoption of ASU 2022-02 did not have a material impact on the Company’s consolidated financial statements. There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on our consolidated financial position, results of operations or cash flows.
Equipment	Equipment The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. In accordance with FASB ASC No. 360, Property, Plant and Equipment,
Fair Value of Financial Instruments	Fair Value of Financial Instruments We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” The three levels of the fair value hierarchy under ASC Topic 820-10 are described below: ● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at December 31, 2023 and 2022. ● Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. ● Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms. The following are the major categories of assets measured at fair value on a recurring basis: as of December 31, 2023 and December 31, 2022, using quoted prices in active markets for identical liabilities (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3): The Company has consistently applied the valuation techniques in all periods presented. The following table presents the Company’s assets which were measured at fair value at December 31, 2023 and December 31, 2022: SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS December 31, 2023 December 31, 2022 Fair Value Measurement Using Fair Value Measurement Using Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets: Investment in gold $ 493,236 $ - $ - $ 493,236 $ 437,251 $ - $ - $ 437,251 Money market fund $ 2,409,486 $ - $ - $ 2,409,486 $ - $ - $ - $ - Total $ 2,902,722 $ - $ - $ 2,902,722 $ 437,251 $ - $ - $ 437,251 The Board of Directors, who serves as the Custodian, is responsible for the safekeeping of gold bullion owned by the Company. Fair value of the gold bullion held by the Company is based on that day’s London Bullion Market Association (“LBMA”) Gold Price PM. “LBMA Gold Price PM” is the price per fine troy ounce of gold, stated in U.S. dollars, determined by ICE Benchmark Administration (“IBA”) following an electronic auction consisting of one or more 30-second rounds starting at 3:00 p.m. (London time), on each day that the London gold market is open for business and published shortly thereafter. The fair value of the treasury bills is based on quoted market prices in an active market. The Company has determined the fair value based on financial factors that are considered level 1 inputs in the fair value hierarchy. Money market funds included in cash and cash equivalents and U.S. government-backed securities are measured at fair value based on quoted prices in active markets, which are considered Level 1 inputs. The Company’s policy is to recognize transfers in and/or out of the fair value hierarchy as of the date in which the event or change in circumstances caused the transfer. The following tables summarize activity in gold bullion for the quarter ended December 31, 2023: SCHEDULE OF GOLD IN BULLION Year Ended December 31, 2023 Ounces Cost Fair Value Balance December 31, 2021 239 $ 1,884 $ 437,212 Net change in unrealized gain - 38 38 Balance December 31, 2022 239 $ 1,829 $ 437,251 Net change in unrealized gain - 235 55,985 Balance December 31, 2023 239 $ 2,064 $ 493,236
Revenue Recognition	Revenue Recognition Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the years ended December 31, 2023 and 2022, the Company recognized $ 0 0
Concentration of Credit Risk	Concentration of Credit Risk The Company at times has cash and cash equivalents in banks in excess of FDIC insurance limits. At December 31, 2023 and December 31, 2022, the Company had approximately $ 2,409,486 3,285,197 On March 12, 2023, the U.S. government took extraordinary steps to stop a potential banking crisis after the historic failure of Silicon Valley Bank, assuring all depositors at the failed institution that they could access all their money quickly, even as another major bank was shut down. The Company had no exposure to a failed bank. The Company averts risks associated with such a crisis by holding minimum cash balances required for uninterrupted operations, federal funds money market fund, and U.S. government-backed securities. As of December 31, 2023, the Company held $ 2,409,486 1. 99.5
Original Issue Discount	Original Issue Discount For certain notes issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded as a debt discount, reducing the face amount of the note, and is amortized to amortization of original issue discount in the consolidated statements of operations over the life of the debt.
Debt Issue Cost	Debt Issue Cost Debt issuance cost paid to lenders, or third parties are recorded as debt discounts and amortized to interest expense in the consolidated statements of operations, over the life of the underlying debt instrument.
Deposit– Related Party	Deposit– Related Party During the year ended December 31, 2022, the Company paid $ 98,480 15% 95,872 0 The Company recognized an impairment expense of $ 95,872 0
Investments without a Readily Determinable Fair Value (Cost Method)	Investments without a Readily Determinable Fair Value (Cost Method) Investments in nonmarketable entities in which the Company is not able to exercise significant influence, our “Cost Method Investments,” are accounted for at our initial cost, minus any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company holds a 15 0

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Tables)	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNING PER SHARE	The computation of basic and diluted loss per share for December 31, 2023 and December 31, 2022 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNING PER SHARE December 31, 2023 December 31, 2022 Stock Warrants (Exercise price - $ 0.001 0.25 67,335,714 54,660,032 Stock Options (Exercise price - $ 0.1150 26,520,000 26,520,000 Convertible Preferred Stock 2 2 Total 93,855,716 81,180,034
SCHEDULE OF COST AND ESTIMATED FAIR VALUE INVESTMENT	The cost and estimated fair value of the Company’s investments are as follows: SCHEDULE OF COST AND ESTIMATED FAIR VALUE INVESTMENT Cost Gross unrealized gain Fair value December 31, 2022 $ - $ - $ - Treasury Bills $ 2,587,811 $ 13,021 $ 2,600,832 Treasury Bills – Redemption $ 2,587,811 $ (13,021 ) $ (2,600,832 ) Total Investments, December 31, 2023 $ - $ - $ -
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)	SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) 2023 2022 Expected income tax (recovery) expense at the statutory rate of 21% $ (636,253 ) $ (806,823 ) Tax effect of expenses that are not deductible for income tax purposes (net of other amounts deductible for tax purposes) 180,647 282,808 Change in valuation allowance 455,606 524,014 Provision for income taxes $ - $ -
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES	The components of deferred income taxes are as follows: SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES 2023 2022 Years Ended December, 2023 2022 Deferred tax liability: $ - $ - Deferred tax asset Net Operating Loss Carryforward 5,342,957 4,887,351 Valuation allowance (5,342,957 ) (4,887,351 ) Net deferred tax asset - - Net deferred tax liability $ - $ -
SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS	SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS December 31, 2023 December 31, 2022 Fair Value Measurement Using Fair Value Measurement Using Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets: Investment in gold $ 493,236 $ - $ - $ 493,236 $ 437,251 $ - $ - $ 437,251 Money market fund $ 2,409,486 $ - $ - $ 2,409,486 $ - $ - $ - $ - Total $ 2,902,722 $ - $ - $ 2,902,722 $ 437,251 $ - $ - $ 437,251
SCHEDULE OF GOLD IN BULLION	The following tables summarize activity in gold bullion for the quarter ended December 31, 2023: SCHEDULE OF GOLD IN BULLION Year Ended December 31, 2023 Ounces Cost Fair Value Balance December 31, 2021 239 $ 1,884 $ 437,212 Net change in unrealized gain - 38 38 Balance December 31, 2022 239 $ 1,829 $ 437,251 Net change in unrealized gain - 235 55,985 Balance December 31, 2023 239 $ 2,064 $ 493,236

EQUIPMENT (Tables)

EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	At December 31, 2023 and December 31, 2022, property and equipment, net, is as follows: SCHEDULE OF PROPERTY AND EQUIPMENT December 31, 2023 December 31, 2022 Estimated Useful Lives (Years) Automobile $ 41,805 $ 41,805 5 Laboratory Equipment 130,310 123,911 5 10 Office Equipment 7,260 7,260 5 10 Leasehold Improvements 82,739 82,739 2 5 Less: Accumulated Depreciation (195,474 ) (167,854 ) Total Property and Equipment, net $ 66,640 $ 87,861

RIGHT TO USE ASSETS AND LEASE_2

RIGHT TO USE ASSETS AND LEASE LIABILITY (Tables)	12 Months Ended
	Dec. 31, 2023
Right To Use Assets And Lease Liability
SCHEDULE OF OPERATING LEASES	At December 31, 2023 and December 31, 2022, the Company had no financing leases as defined in ASC 842, “Leases.” SCHEDULE OF OPERATING LEASES December 31, 2023 December 31, 2022 Assets Operating lease - right-of-use asset - non-current $ 95,808 $ 58,849 Liabilities Operating lease liability $ 96,157 $ 59,897 Weighted-average remaining lease term (three months) 1.95 2.08 Weighted-average discount rate 8 % 8 % The components of lease expense were as follows: Operating lease costs Amortization of right-of-use operating lease asset $ 20,194 $ 52,043 Total operating lease costs $ 20,194 $ 52,043 Supplemental cash flow information related to operating leases was as follows: Operating cash outflows from operating lease (obligation payment) $ 53,442 $ 51,344 Right-of-use asset obtained in exchange for new operating lease liability $ - $ -
SCHEDULE OF MINIMUM LEASE PAYMENTS	Future minimum lease payments required under leases that have initial or remaining non-cancelable lease terms in excess of one year at December 31, 2023: SCHEDULE OF MINIMUM LEASE PAYMENTS 2024 $ 54,144 2025 44,344 2026 5,764 Total lease payments 104,252 Less: amount representing interest (8,095 ) Total lease obligations 96,157 Less: current portion of operating lease liability (41,789 ) Long-term portion operating lease liability $ 54,368

CONVERTIBLE NOTES (Tables)

CONVERTIBLE NOTES (Tables)	12 Months Ended
	Dec. 31, 2023
Convertible Notes
SCHEDULE OF FAIR VALUE WARRANTS	SCHEDULE OF FAIR VALUE WARRANTS Stock Price $ 0.14 Exercise price $ 0.16 Expected term (in years) 5 Expected volatility 60.64 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.10 % Stock Price $ 0.15 Exercise price $ 0.25 Expected term (in years) 5 Expected volatility 100.76 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.07 % Stock Price $ 0.08 Exercise price $ 0.12 0.14 Expected term (in years) 5 Expected volatility 124.10 % Annual rate of quarterly dividends 0 % Risk free interest rate 0.58 %
SUMMARY OF CONVERTIBLE DEBT	The following represents a summary of the Company’s convertible debt at December 31, 2023: SUMMARY OF CONVERTIBLE DEBT Convertible Note Payable Amounts Balance – December 31, 2021 $ 503,423 Proceeds 3,000,000 Debt discount and issue costs recorded (865,000 ) Conversion of debt into common shares (3,750,003 ) Amortization of debt discount 1,111,580 Balance – December 31, 2022 $ - No activity – December 31, 2023 - Balance – December 31, 2023 $ - Accrued Interest Payable Amounts Balance – December 31, 2021 31,657 Interest Expense December 31, 2022 153,955 Interest conversion into common shares (185,612 ) Balance – December 31, 2022 $ - No activity – December 31, 2023 - Balance – December 31, 2023 $ -

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
SCHEDULE OF OPTION ASSUMPTION	SCHEDULE OF OPTION ASSUMPTION Expected dividends 0 % Expected volatility 133.30 % Expected term 5 Risk free interest rate 4.00 % Expected forfeitures 0 % Expected dividends 0 % Expected volatility 133.30 % Expected term 6.25 Risk free interest rate 4.04 % Expected forfeitures 0 % Expected dividends 0 % Expected volatility 133.30 % Expected term 6.25 Risk free interest rate 4.04 % Expected forfeitures 0 % Expected dividends 0 % Expected volatility 133.22 % Expected term 7 Risk free interest rate 1.46 % Expected forfeitures 0 % Expected dividends 0 % Expected volatility 125.19 % Expected term 3 Risk free interest rate 1.50 % Expected forfeitures 0 % Expected dividends 0 % Expected volatility 125.19 % Expected term 6 Risk free interest rate 1.46 % Expected forfeitures 0 %
SCHEDULE OF WARRANTS ACTIVITY	Warrant activity as of December 31, 2023 is summarized as follows: SCHEDULE OF WARRANTS ACTIVITY Warrants Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding - December 31, 2021 48,972,279 $ 0.12 2.64 $ 1,248,452 Exercisable - December 31, 2021 48,972,279 $ 0.12 2.64 $ 1,248,452 Granted 16,785,714 $ 0.12 4.05 - Exercised (11,097,959 ) $ 0.07 - - Cancelled/Forfeited - $ - - - Outstanding - December 31, 2022 54,660,034 $ 0.13 3.04 $ 319,000 Exercisable - December 31, 2022 54,660,034 $ 0.13 3.04 $ 319,000 Granted 20,000,000 $ 0.04 8.96 - Exercised (2,500,000 ) $ 0.001 - - Cancelled/Forfeited (4,824,320 ) $ 0.11 - - Outstanding – December 31, 2023 67,335,714 $ 0.12 3.89 $ 331,500 Exercisable – December 31, 2023 67,335,714 $ 0.12 3.89 $ 331,500
SCHEDULE OF WARRANTS OUTSTANDING	As of December 31, 2023, the following warrants were outstanding: SCHEDULE OF WARRANTS OUTSTANDING Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate Intrinsic Value $ 0.001 8,500,000 2.14 $ 331,500 $ 0.04 2,300,000 2.75 $ - $ 0.056 1,000,000 1.52 $ - $ 0.2299 7,125,000 1.27 $ - $ 0.16 3,125,000 1.95 $ - $ 0.25 8,000,000 2.23 $ - $ 0.1160 500,000 1.52 $ - $ 0.12 12,500,000 3.05 $ - $ 0.14 4,285,714 3.05 $ - $ 0.04 4,000,000 9.95 $ - $ 0.04 6,000,000 9.95 $ - $ 0.04 10,000,000 9.95 $ - 67,335,714 $ 331,500 For the year ended December 31, 2022, the following warrants were outstanding: Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate Intrinsic Value $ 0.001 11,000,000 3.43 $ 321,000 $ 0.04 2,300,000 3.75 $ - $ 0.056 1,000,000 2.02 $ - $ 0.08 3,699,320 0.18 $ - $ 0.2299 8,250,000 2.21 $ - $ 0.16 3,125,000 2.95 $ - $ 0.25 8,000,000 3.23 $ - $ 0.1160 500,000 2.52 $ - $ 0.12 12,500,000 4.05 $ - $ 0.14 4,285,714 4.05 $ - 54,660,034 $ 321,000
SCHEDULE OF OPTIONS ACTIVITY	Options activity as of December 31, 2023 is summarized as follows: SCHEDULE OF OPTIONS ACTIVITY Options Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding - December 31, 2021 26,802,500 $ 0.12 19.12 $ - Exercisable - December 31, 2021 26,802,500 $ 0.12 19.12 $ - Granted - $ - - - Exercised - $ - - - Cancelled/Forfeited (282,500 ) $ 0.12 5.00 - Outstanding - December 31, 2022 26,520,000 $ 0.12 18.27 $ - Granted - $ - - - Exercised - $ - - - Cancelled/Forfeited - $ - - - Outstanding – December 31, 2023 26,520,000 $ 0.12 17.27 $ - Exercisable – December 31, 2023 26,520,000 $ 0.12 17.27 $ -
SCHEDULE OF OPTIONS OUTSTANDING	For the year ended December 31, 2023, the following options were outstanding: SCHEDULE OF OPTIONS OUTSTANDING Exercise Price Options Outstanding Options Exercisable Weighted Average Remaining Contractual Life (in Years) $ 0.115 26,520,000 26,520,000 17.27 For the year ended December 31, 2022, the following options were outstanding: Exercise Price Options Outstanding Options Exercisable Weighted Average Remaining Contractual Life (in Years) $ 0.115 26,520,000 26,520,000 18.52

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES RELATED PARTY	Accounts payable and accrued expenses – related party consists of the following: SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES RELATED PARTY As of As of Accounts payable - related party $ 388,001 $ 356,191 Accrued expenses - related party 3,516,411 3,082,363 Accrued interest - related party 2,680,236 2,276,454 Total accounts payable and accrued expenses - related party $ 6,584,648 $ 5,715,008

SCHEDULE OF ANTIDILUTIVE SECURI

SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNING PER SHARE (Details) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	93,855,716	81,180,034
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	67,335,714	54,660,032
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	26,520,000	26,520,000
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	2	2

SCHEDULE OF ANTIDILUTIVE SECU_2

SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNINGS PER SHARE (Details) (Parenthetical) - $ / shares	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Option exercise price	$ 0.12	$ 0.12	$ 0.12
Minimum [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrant exercise price per share		0.06
Maximum [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrant exercise price per share		0.08
Warrant [Member] | Minimum [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrant exercise price per share	0.001	0.001
Warrant [Member] | Maximum [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrant exercise price per share	0.25	0.25
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Option exercise price	$ 0.1150	$ 0.1150

SCHEDULE OF COST AND ESTIMATED

SCHEDULE OF COST AND ESTIMATED FAIR VALUE INVESTMENT (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Line Items]
Investment cost
Investment gross unrealized gain
Investment fair value
US Treasury Securities [Member]
Cash and Cash Equivalents [Line Items]
Investment cost	2,587,811
Investment gross unrealized gain	13,021
Investment fair value	2,600,832
US Treasury Securities - Redemption [Member]
Cash and Cash Equivalents [Line Items]
Investment cost	2,587,811
Investment gross unrealized gain	(13,021)
Investment fair value	$ (2,600,832)

SCHEDULE OF COMPONENTS OF INCOM

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Expected income tax (recovery) expense at the statutory rate of 21%	$ (636,253)	$ (806,823)
Tax effect of expenses that are not deductible for income tax purposes (net of other amounts deductible for tax purposes)	180,647	282,808
Change in valuation allowance	455,606	524,014
Provision for income taxes

SCHEDULE OF COMPONENTS OF INC_2

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) (Parenthetical)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Statutory rate	21%	21%

SCHEDULE OF DEFERRED TAX ASSETS

SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Deferred tax liability:
Deferred tax asset
Net Operating Loss Carryforward	5,342,957	4,887,351
Valuation allowance	(5,342,957)	(4,887,351)
Net deferred tax asset
Net deferred tax liability

SCHEDULE OF FAIR VALUE OF FINAN

SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets	$ 2,902,722	$ 437,251
Investment in Gold [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets	493,236	437,251
Money Market Funds [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets	2,409,486
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets	2,902,722	437,251
Fair Value, Inputs, Level 1 [Member] | Investment in Gold [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets	493,236	437,251
Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets	2,409,486
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets
Fair Value, Inputs, Level 2 [Member] | Investment in Gold [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets
Fair Value, Inputs, Level 2 [Member] | Money Market Funds [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets
Fair Value, Inputs, Level 3 [Member] | Investment in Gold [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets
Fair Value, Inputs, Level 3 [Member] | Money Market Funds [Member]
Platform Operator, Crypto-Asset [Line Items]
Fair value of assets

SCHEDULE OF GOLD IN BULLION (De

SCHEDULE OF GOLD IN BULLION (Details)	12 Months Ended
	Dec. 31, 2023 USD ($) oz	Dec. 31, 2022 USD ($) oz
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Beginning balance, ounce | oz	239	239
Beginning balance, cost	$ 1,829	$ 1,884
Beginning balalnce, fair value	$ 437,251	$ 437,212
Net change in unrealized gain (loss), ounce | oz
Net change in unrealized gain (loss), cost	$ 235	$ 38
Net change in unrealized gain (loss), fair value	$ 55,985	$ 38
Ending balance, ounce | oz	239	239
Ending balance, cost	$ 2,064	$ 1,829
Ending balance, fair value	$ 493,236	$ 437,251

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash equivalents	$ 2,551,834	$ 3,862,716
Available for sale securities debt securities
Research and development costs	237,871	176,431
Advertising expenses	0	0
Valuation allowance increase decrease	455,606	524,014
Revenue
Cash excess of FDIC insurance limits	2,409,486	3,285,197
Federal money market fund	$ 2,409,486
Share price	$ 1
Funds invests, percentage	99.50%
Deposits paid		$ 98,480
Ownership interest percentage		15%
Deposits	$ 95,872
Remaining deposits	0
Asset impairment expense	$ 95,872
Global Silk Solutions [Member]
Equity investment percentage	15%

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital deficit	$ 6,311,990
Stockholders' deficiency	5,707,156	$ 3,521,860	$ 5,295,875
Cash used in operating activities	$ 1,244,483	$ 1,887,187

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Less: Accumulated Depreciation	$ (195,474)	$ (167,854)
Total Property and Equipment, net	66,640	87,861
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Leasehold Improvements	$ 41,805	41,805
Estimated useful lives (years)	5 years
Laboratory Equipment [Member]
Property, Plant and Equipment [Line Items]
Leasehold Improvements	$ 130,310	123,911
Laboratory Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	5 years
Laboratory Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	10 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Leasehold Improvements	$ 7,260	7,260
Office Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	5 years
Office Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	10 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Leasehold Improvements	$ 82,739	$ 82,739
Leasehold Improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	2 years
Leasehold Improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives (years)	5 years

EQUIPMENT (Details Narrative)

EQUIPMENT (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 27,620	$ 28,103

SCHEDULE OF OPERATING LEASES (D

SCHEDULE OF OPERATING LEASES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Right To Use Assets And Lease Liability
Operating lease - right-of-use asset - non-current	$ 95,808	$ 58,849
Operating lease liability	$ 96,157	$ 59,897
Weighted-average remaining lease term (years)	1 year 11 months 12 days	2 years 29 days
Weighted-average discount rate	8%	8%
Amortization of right-of-use operating lease asset	$ 20,194	$ 52,043
Total operating lease costs	20,194	52,043
Operating cash outflows from operating lease (obligation payment)	53,442	51,344
Right-of-use asset obtained in exchange for new operating lease liability

SCHEDULE OF MINIMUM LEASE PAYME

SCHEDULE OF MINIMUM LEASE PAYMENTS (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Sep. 05, 2019	Sep. 13, 2017
Right To Use Assets And Lease Liability
2024	$ 54,144		$ 42,000	$ 39,200
2025	44,344		$ 44,800	$ 42,000
2026	5,764
Total lease payments	104,252
Less: amount representing interest	(8,095)
Total lease obligations	96,157	$ 59,897
Less: current portion of operating lease liability	(41,789)	(39,200)
Long-term portion operating lease liability	$ 54,368	$ 20,697

RIGHT TO USE ASSETS AND LEASE_3

RIGHT TO USE ASSETS AND LEASE LIABILITY (Details Narrative)			12 Months Ended
	Apr. 16, 2021 USD ($)	May 09, 2019 USD ($) m²	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jul. 01, 2021 USD ($) m²	Sep. 05, 2019 USD ($) ft²	Sep. 13, 2017 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lease term						2 years
Area of land | ft²						5,000
Annual rent, year one			$ 54,144			$ 42,000	$ 39,200
Annual rent, year two			44,344			$ 44,800	$ 42,000
Operating lease, right-of-use asset			95,808	$ 58,849
Lease liabilities			41,789	$ 39,200
Socialist Republic of Vietnam [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lease term		5 years			5 years
Area of land | m²		4,560.57			6,000
Annual rent, year one		$ 45,150			$ 8,645
Annual rent, year two		$ 45,150
Operating lease, right-of-use asset					$ 241,800
Rent increase percentage		5%
Operating Lease Agreements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Payments for rent	$ 42,000		2,508
Operating Lease Agreements [Member] | October 1, 2022 through September 30, 2023 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Payments for rent			44,800
Operating Lease Agreements [Member] | October 1, 2023 through September 30, 2024 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Payments for rent			44,800
Operating Lease Agreements [Member] | October 1, 2024 through September 30, 2025 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Payments for rent			47,600
Operating Lease Agreements [Member] | October 1, 2024 through September 30, 2025 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Payments for rent			47,600
Adoption of New Guidance [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease, right-of-use asset			79,862
Lease liabilities			79,862
Adoption of New Guidance [Member] | October 1, 2024 through September 30, 2025 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease, right-of-use asset			85,022
Lease liabilities			$ 85,022

NOTE PAYABLE _ RELATED PARTY (D

NOTE PAYABLE – RELATED PARTY (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jan. 26, 2022	Dec. 01, 2020
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Paid-in-kind interest	$ 80,851	$ 80,849
Accured interest payable	56,050	54,755
Interest payable	246,714	107,882
Related Party [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Notes payable, related parties, current	$ 1,617,000	$ 1,617,000	$ 40,000
Chief Executive Officer [Member] | Related Party [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Notes payable, related parties, current				$ 1,657,000
Loans received bear interest				3%

LOAN PAYABLE (Details Narrative

LOAN PAYABLE (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jul. 08, 2021	Mar. 01, 2019
Short-Term Debt [Line Items]
Notes Payable			$ 180,244
Repayment of debt	$ 60,000	$ 60,000
Loan balance	35,244	$ 95,244
First Nine Months [Member]
Short-Term Debt [Line Items]
Repayment of debt	1,000
Seven and Eight Months [Member]
Short-Term Debt [Line Items]
Repayment of debt	2,000
Nine Through Twenty Three Months [Member]
Short-Term Debt [Line Items]
Repayment of debt	5,000
24th Month [Member]
Short-Term Debt [Line Items]
Repayment of debt	180,224
13 Months [Member]
Short-Term Debt [Line Items]
Repayment of debt	5,000
Two Equal Pyments [Member]
Short-Term Debt [Line Items]
Repayment of debt	115,244
14 Months [Member]
Short-Term Debt [Line Items]
Repayment of debt	57,622
20 Months [Member]
Short-Term Debt [Line Items]
Repayment of debt	57,622
Months Fourteen And Twenty [Member]
Short-Term Debt [Line Items]
Repayment of debt	$ 5,000
Notre Dame [Member] | Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Notes Payable				$ 265,244
Note bears interest rate percentage				10%

SCHEDULE OF FAIR VALUE WARRANTS

SCHEDULE OF FAIR VALUE WARRANTS (Details)	Jan. 18, 2022 $ / shares	Mar. 25, 2021 $ / shares	Dec. 11, 2020 $ / shares
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.08	0.15	0.14
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage		0.25	0.16
Measurement Input, Exercise Price [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.12
Measurement Input, Exercise Price [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.14
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants term	5 years	5 years	5 years
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	124.10	100.76	60.64
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0	0	0
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input, percentage	0.58	0.07	0.10

SUMMARY OF CONVERTIBLE DEBT (De

SUMMARY OF CONVERTIBLE DEBT (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Short-Term Debt [Line Items]
Proceeds - net		$ 2,760,000
Amortization of debt discount		1,111,580
Balance, beginning		31,657
Interest expense		153,955
Interest conversion into common shares		(185,612)
Balance, ending
Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Balance, beginning		503,423
Proceeds - net		3,000,000
Debt discount and issue costs recorded		(865,000)
Conversion of debt into common shares		(3,750,003)
Amortization of debt discount		1,111,580
Balance, ending

CONVERTIBLE NOTES (Details Narr

CONVERTIBLE NOTES (Details Narrative) - USD ($)																												12 Months Ended
	Nov. 17, 2022	Nov. 14, 2022	Nov. 01, 2022	Oct. 31, 2022	Oct. 26, 2022	Oct. 18, 2022	Oct. 11, 2022	Sep. 26, 2022	Sep. 08, 2022	Aug. 18, 2022	Jul. 19, 2022	Jun. 30, 2022	Jun. 21, 2022	Jun. 14, 2022	Jun. 06, 2022	May 17, 2022	Apr. 29, 2022	Apr. 14, 2022	Apr. 11, 2022	Feb. 16, 2022	Jan. 31, 2022	Jan. 21, 2022	Jan. 18, 2022	Apr. 22, 2021	Apr. 06, 2021	Mar. 25, 2021	Dec. 11, 2020	Dec. 31, 2023	Dec. 31, 2022	Feb. 15, 2022
Debt Instrument [Line Items]
Number of warrants issued																														7,398,639
Interest payable																												$ 246,714	$ 107,882
Proceeds from convertible debt																													2,760,000
Issuance of convertible securities																													$ 3,935,615
Common Stock [Member]
Debt Instrument [Line Items]
Number of warrants issued																														3,699,320
Debt conversion, converted instrument, amount	$ 150,000	$ 150,000	$ 250,000	$ 150,000	$ 150,000	$ 150,000	$ 100,000	$ 150,000	$ 150,000	$ 200,000	$ 200,000	$ 150,000	$ 150,000	$ 100,000	$ 200,000	$ 200,000	$ 250,000	$ 150,000		$ 250,000	$ 250,000	$ 250,000
Debt conversion, converted instrument, shares issued	5,935,350	5,974,335	9,236,212	6,510,348	5,487,951	4,782,778	2,907,240	3,605,259	3,396,898	4,325,913	4,364,987	3,401,877	3,393,979	2,902,922	3,549,793	3,628,325	4,272,417	2,358,380		3,924,443	4,569,059	3,935,417
Interest payable	$ 164	$ 1,151	$ 301	$ 28,384	$ 370	$ 658	$ 1,753	$ 2,863	$ 4,219	$ 7,644	$ 6,027	$ 3,425	$ 3,068	$ 60,822	$ 5,178	$ 5,726	$ 5,918	$ 1,644		$ 1,164	$ 42,877	$ 2,260
Unsecured Convertible Note [Member]
Debt Instrument [Line Items]
Number of warrants issued																							12,000,000			8,000,000	3,125,000		4,285,714
Warrant term																							5 years			5 years	5 years
Fair value adjustments of warrants																							$ 1,071,437			$ 3,359,716	$ 2,599,066
Debt instrument, discount																							10,000			3,670,000	1,000,000
Debt issuance costs																			$ 115,000				$ 115,000			$ 330,000	$ 86,000
Debt instrument term																			13 months				13 months			1 year
Debt conversion, converted instrument, amount																							$ 1,500,000			$ 4,000,000
Debt instrument, interest rate																			10%				10%
Debt instrument, description																			The note contained a discount to market feature, whereby, the lender could purchase stock at 85% of the lowest trading price for a period of ten (10) days preceding the conversion date. As of November 17, 2022 this debenture was satisfied.				The note contained a discount to market feature, whereby, the lender could purchase stock at 85% of the lowest trading price for a period of ten (10) days preceding the conversion date. As of October 26, 2022 this debenture was satisfied.
Debt instrument, maturity date																			May 11, 2023				Feb. 18, 2023
Proceeds from convertible debt																							$ 1,490,000
Exercise price																							$ 0.12						$ 0.14
Issuance of convertible securities																			$ 1,500,000				$ 1,500,000
Class of warrant issued																							16,785,714
Debt fair value																							$ 625,003
Unsecured Convertible Note [Member] | First Convertible Debenture [Member]
Debt Instrument [Line Items]
Debt conversion, converted instrument, amount																										$ 500,000
Debt instrument, interest rate																										10%
Debt instrument, description																										The note contained a discount to market feature, whereby, the lender could purchase stock at 80% of the lowest trading price for a period of ten (10) days preceding the conversion date.
Unsecured Convertible Note [Member] | Second Convertible Debenture [Member]
Debt Instrument [Line Items]
Debt conversion, converted instrument, amount																									$ 500,000
Unsecured Convertible Note [Member] | Third Convertible Debenture [Member]
Debt Instrument [Line Items]
Debt conversion, converted instrument, amount																								$ 3,000,000

SCHEDULE OF OPTION ASSUMPTION (

SCHEDULE OF OPTION ASSUMPTION (Details)	Dec. 13, 2023	Jan. 25, 2021	Feb. 19, 2020
10-Year Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected dividends	0%
Expected volatility	133.30%
Expected term	5 years
Risk free interest rate	4%
Expected forfeitures	0%
5-Year Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected dividends	0%
Expected volatility	133.30%
Expected term	6 years 3 months
Risk free interest rate	4.04%
Expected forfeitures	0%
5-Year Option One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected dividends	0%
Expected volatility	133.30%
Expected term	6 years 3 months
Risk free interest rate	4.04%
Expected forfeitures	0%
7-Year Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected dividends		0%
Expected volatility		133.22%
Expected term		7 years
Risk free interest rate		1.46%
Expected forfeitures		0%
10-Year Option One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected dividends			0%
Expected volatility			125.19%
Expected term			3 years
Risk free interest rate			1.50%
Expected forfeitures			0%
7-Year Option One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected dividends			0%
Expected volatility			125.19%
Expected term			6 years
Risk free interest rate			1.46%
Expected forfeitures			0%

SCHEDULE OF WARRANTS ACTIVITY (

SCHEDULE OF WARRANTS ACTIVITY (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Equity [Abstract]
Number of Warrants, Outstanding, Beginning balance	54,660,034	48,972,279
Weighted Average Exercise Price, Outstanding, Beginning balance	$ 0.13	$ 0.12
Weighted Average Remaining Contractual Life (In Years)	3 years 10 months 20 days	3 years 14 days	2 years 7 months 20 days
Aggregate Intrinsic Value, Outstanding, Beginning balance	$ 321,000	$ 1,248,452
Number of Warrants, Exercisable, Beginning balance	54,660,034	48,972,279
Weighted Average Exercise Price, Exercisable, Beginning balance	$ 0.13	$ 0.12
Weighted Average Remaining Contractual Life (In Years), Exercisable	3 years 10 months 20 days	3 years 14 days	2 years 7 months 20 days
Aggregate Intrinsic Value, Exercisable, Beginning balance	$ 319,000	$ 1,248,452
Number of Warrants, Granted	20,000,000	16,785,714
Weighted Average Exercise Price, Granted	$ 0.04	$ 0.12
Weighted Average Remaining Contractual Life (In Years), Granted	8 years 11 months 15 days	4 years 18 days
Number of Warrants, Exercised	(2,500,000)	(11,097,959)
Weighted Average Exercise Price, Exercised	$ 0.001	$ 0.07
Number of Warrants, Cancelled/Forfeited	(4,824,320)
Weighted Average Exercise Price, Cancelled/Forfeited	$ 0.11
Aggregate Intrinsic Value, Outstanding, Beginning balance	$ 319,000
Number of Warrants, Outstanding, Ending balance	67,335,714	54,660,034	48,972,279
Weighted Average Exercise Price, Outstanding, Ending balance	$ 0.12	$ 0.13	$ 0.12
Aggregate Intrinsic Value, Outstanding, Ending balance	$ 331,500	$ 321,000	$ 1,248,452
Number of Warrants, Exercisable, Ending balance	67,335,714	54,660,034	48,972,279
Weighted Average Exercise Price, Exercisable, Ending balance	$ 0.12	$ 0.13	$ 0.12
Aggregate Intrinsic Value, Exercisable, Ending balance	$ 331,500	$ 319,000	$ 1,248,452

SCHEDULE OF WARRANTS OUTSTANDIN

SCHEDULE OF WARRANTS OUTSTANDING (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Exercisable	67,335,714	54,660,034	48,972,279
Aggregate Intrinsic Value	$ 331,500	$ 321,000	$ 1,248,452
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.001	$ 0.001
Warrants Exercisable	8,500,000	11,000,000
Weighted Average Remaining Contractual Life	2 years 1 month 20 days	3 years 5 months 4 days
Aggregate Intrinsic Value	$ 331,500	$ 321,000
Warrant One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.04	$ 0.04
Warrants Exercisable	2,300,000	2,300,000
Weighted Average Remaining Contractual Life	2 years 9 months	3 years 9 months
Aggregate Intrinsic Value
Warrant Two [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.056	$ 0.056
Warrants Exercisable	1,000,000	1,000,000
Weighted Average Remaining Contractual Life	1 year 6 months 7 days	2 years 7 days
Aggregate Intrinsic Value
Warrant Three [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.2299	$ 0.08
Warrants Exercisable	7,125,000	3,699,320
Weighted Average Remaining Contractual Life	1 year 3 months 7 days	2 months 4 days
Aggregate Intrinsic Value
Warrant Four [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.16	$ 0.2299
Warrants Exercisable	3,125,000	8,250,000
Weighted Average Remaining Contractual Life	1 year 11 months 12 days	2 years 2 months 15 days
Aggregate Intrinsic Value
Warrant Five [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.25	$ 0.16
Warrants Exercisable	8,000,000	3,125,000
Weighted Average Remaining Contractual Life	2 years 2 months 23 days	2 years 11 months 12 days
Aggregate Intrinsic Value
Warrant Six [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.1160	$ 0.25
Warrants Exercisable	500,000	8,000,000
Weighted Average Remaining Contractual Life	1 year 6 months 7 days	3 years 2 months 23 days
Aggregate Intrinsic Value
Warrant Seven [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.12	$ 0.1160
Warrants Exercisable	12,500,000	500,000
Weighted Average Remaining Contractual Life	3 years 18 days	2 years 6 months 7 days
Aggregate Intrinsic Value
Warrant Eight [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.14	$ 0.12
Warrants Exercisable	4,285,714	12,500,000
Weighted Average Remaining Contractual Life	3 years 18 days	4 years 18 days
Aggregate Intrinsic Value
Warrant Nine [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.04	$ 0.14
Warrants Exercisable	4,000,000	4,285,714
Weighted Average Remaining Contractual Life	9 years 11 months 12 days	4 years 18 days
Aggregate Intrinsic Value
Warrant Ten [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.04
Warrants Exercisable	6,000,000
Weighted Average Remaining Contractual Life	9 years 11 months 12 days
Aggregate Intrinsic Value
Warrant Eleven [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price	$ 0.04
Warrants Exercisable	10,000,000
Weighted Average Remaining Contractual Life	9 years 11 months 12 days
Aggregate Intrinsic Value

SCHEDULE OF OPTIONS ACTIVITY (D

SCHEDULE OF OPTIONS ACTIVITY (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Equity [Abstract]
Number of Options, Outstanding, Beginning balance	26,520,000	26,802,500
Weighted Average Exercise Price, Outstanding, Beginning balance	$ 0.12	$ 0.12
Weighted Average Remaining Contractual Life (In Years)	17 years 3 months 7 days	18 years 3 months 7 days	19 years 1 month 13 days
Aggregate Intrinsic Value, Outstanding, Beginning balance
Number of Options, Outstanding, Exercisable		26,802,500
Weighted Average Exercise Price, Outstanding, Exercisable		$ 0.12
Weighted Average Remaining Contractual Life (In Years), Exercisable	17 years 3 months 7 days		19 years 1 month 13 days
Aggregate Intrinsic Value, Exercisable, Beginning balance
Number of Options, Outstanding, Granted
Weighted Average Exercise Price, Outstanding, Granted
Number of Options, Outstanding, Exercised
Weighted Average Exercise Price, Outstanding, Exercised
Number of Options, Outstanding, Cancelled/Forfeited		(282,500)
Weighted Average Exercise Price, Outstanding, Cancelled/Forfeited		$ 0.12
Weighted Average Remaining Contractual Life (In Years), Cancelled/Forfeited		5 years
Number of Options, Outstanding, Ending balance	26,520,000	26,520,000	26,802,500
Weighted Average Exercise Price, Outstanding, Ending balance	$ 0.12	$ 0.12	$ 0.12
Aggregate Intrinsic Value, Outstanding, Ending balance
Number of Options, Outstanding, Exercisable	26,520,000		26,802,500
Weighted Average Exercise Price, Outstanding, Exercisable	$ 0.12		$ 0.12
Aggregate Intrinsic Value, Exercisable, Ending balance

SCHEDULE OF OPTIONS OUTSTANDING

SCHEDULE OF OPTIONS OUTSTANDING (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Exercise Price	$ 0.115	$ 0.115
Options Outstanding	26,520,000	26,520,000
Options Exercisable	26,520,000	26,520,000
Weighted Average Remaining Contractual Life	17 years 3 months 7 days	18 years 6 months 7 days

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)																														12 Months Ended
	Dec. 26, 2023	Dec. 13, 2023	Feb. 16, 2023	Nov. 17, 2022	Nov. 14, 2022	Nov. 01, 2022	Oct. 31, 2022	Oct. 26, 2022	Oct. 18, 2022	Oct. 11, 2022	Sep. 26, 2022	Sep. 08, 2022	Aug. 18, 2022	Jul. 19, 2022	Jun. 30, 2022	Jun. 21, 2022	Jun. 14, 2022	Jun. 06, 2022	May 17, 2022	Apr. 29, 2022	Apr. 14, 2022	Feb. 16, 2022	Feb. 15, 2022	Jan. 31, 2022	Jan. 21, 2022	Jan. 25, 2021	Feb. 19, 2020	Mar. 09, 2019	Feb. 16, 2009	Dec. 31, 2023	Dec. 31, 2022	Dec. 17, 2013
Class of Stock [Line Items]
Stock issued during period shares new issues			2,434,211																				7,398,639
Share price																														$ 1
Stock issued during period shares issuance of common stock																							7,398,639
Stock issued during period value new issues																							$ 443,918
Stock issued during period value issued for services																														$ 225,000
Granted per share
Cashless exercise warrants			2,500,000
Options to purchase shares
Preferred stock, shares authorized																													Unlimited	Unlimited	Unlimited
Preferred stock, no par value																													$ 0	$ 0	$ 0
Accrued interest																														$ 246,714	$ 107,882
10-Year Option [Member]
Class of Stock [Line Items]
Share price		$ 0.04
Options to purchase shares		1,000,000
Fair value of options		$ 260,000
Share-Based payment arrangement, expense																														260,000
5-Year Option [Member]
Class of Stock [Line Items]
Share price		$ 0.04
Options to purchase shares		6,000,000
Fair value of options		$ 162,000
Share-Based payment arrangement, expense																														32,400
Common stock warrants and options, description		Options vest 20% on the grant date, 20% will vest on the second anniversary, 20% will vest on the third-year anniversary, 20% will vest on the fourth year anniversary as long as the employee remains with the Company at the end of each successive year for four years. Options will be exercisable on December 31, 2023, and for a period of 10 years expiring on December 13, 2033.
5-Year Option One [Member]
Class of Stock [Line Items]
Share price		$ 0.04
Options to purchase shares		4,000,000
Fair value of options		$ 108,000
Share-Based payment arrangement, expense																														21,600
Common stock warrants and options, description		Options vest 20% on the grant date, 20% will vest on the second anniversary, 20% will vest on the third-year anniversary, 20% will vest on the fourth year anniversary as long as the employee remains with the Company at the end of each successive year for four years. Options will be exercisable on December 31, 2023, and for a period of 10 years expiring on December 13, 2033.
7-Year Option [Member]
Class of Stock [Line Items]
Share price																										$ 0.134
Options to purchase shares																										2,500,000
Fair value of options																										$ 310,165
Share-Based payment arrangement, expense																														93,752
Common stock warrants and options, description																										Options vest 33.3% on the year one anniversary of the grant date, 33.3% will vest on the second anniversary, and 33.3% will vest on the third year anniversary as long as the employee remains with the Company at the end of each successive year for three years. Options will be exercisable on January 25, 2021, and for a period of 7 years expiring on January 25, 2028.
10-Year Option One [Member]
Class of Stock [Line Items]
Share price																											$ 0.115
Options to purchase shares																											6,000,000
Fair value of options																											$ 626,047
Share-Based payment arrangement, expense																														104,270
Options description																											Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030.
7-Year Option One [Member]
Class of Stock [Line Items]
Share price																											$ 0.115
Options to purchase shares																											1,340,000
Fair value of options																											$ 133,063
Share-Based payment arrangement, expense																														$ 26,594
Options description																											Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027.
Warrant [Member]
Class of Stock [Line Items]
Warrant exercise price per share																														$ 0.001	$ 0.001
Warrant One [Member]
Class of Stock [Line Items]
Warrant exercise price per share																														0.04	0.04
Warrant Two [Member]
Class of Stock [Line Items]
Warrant exercise price per share																														0.056	0.056
Warrant Three [Member]
Class of Stock [Line Items]
Warrant exercise price per share																														$ 0.2299	$ 0.08
Common Stock [Member]
Class of Stock [Line Items]
Stock issued during period shares new issues																							3,699,320
Stock issued during period shares issuance of common stock																							3,699,320
Stock issued during period value new issues																							$ 295,946
Debt conversion, converted instrument, shares issued				5,935,350	5,974,335	9,236,212	6,510,348	5,487,951	4,782,778	2,907,240	3,605,259	3,396,898	4,325,913	4,364,987	3,401,877	3,393,979	2,902,922	3,549,793	3,628,325	4,272,417	2,358,380	3,924,443		4,569,059	3,935,417
Debt conversion, converted instrument, amount				$ 150,000	$ 150,000	$ 250,000	$ 150,000	$ 150,000	$ 150,000	$ 100,000	$ 150,000	$ 150,000	$ 200,000	$ 200,000	$ 150,000	$ 150,000	$ 100,000	$ 200,000	$ 200,000	$ 250,000	$ 150,000	$ 250,000		$ 250,000	$ 250,000
Accrued interest				$ 164	$ 1,151	$ 301	$ 28,384	$ 370	$ 658	$ 1,753	$ 2,863	$ 4,219	$ 7,644	$ 6,027	$ 3,425	$ 3,068	$ 60,822	$ 5,178	$ 5,726	$ 5,918	$ 1,644	$ 1,164		$ 42,877	$ 2,260
Common Class A [Member]
Class of Stock [Line Items]
Stock issued during period shares issued for services	5,000,000
Stock issued during period value issued for services	$ 225,000
Granted per share	$ 0.045
Common stock, shares authorized																													Unlimited	Unlimited	Unlimited
Common stock, no par value																													$ 0	$ 0	$ 0
Common Class A [Member] | Common Stock [Member]
Class of Stock [Line Items]
Stock issued during period shares issued for services																														5,000,000
Stock issued during period value issued for services																														$ 225,000
Cashless exercise warrants																														2,434,211
Common Class B [Member]
Class of Stock [Line Items]
Common stock, shares authorized																													Unlimited	Unlimited	Unlimited
Common stock, no par value																													$ 0	$ 0	$ 0
Common Class B [Member] | Common Stock [Member]
Class of Stock [Line Items]
Stock issued during period value issued for services
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, no par value																														$ 0	$ 0	$ 0
Preferred stock, shares authorized																																2
Purchase Agreement [Member] | Warrant [Member]
Class of Stock [Line Items]
Warrant exercise price per share																												$ 0.06
Warrant expire																												Mar. 08, 2021
Purchase Agreement [Member] | Warrant One [Member]
Class of Stock [Line Items]
Warrant exercise price per share																												$ 0.06
Warrant expire																												Mar. 08, 2022
Purchase Agreement [Member] | Warrant Two [Member]
Class of Stock [Line Items]
Warrant exercise price per share																												$ 0.08
Warrant expire																												Mar. 08, 2022
Purchase Agreement [Member] | Warrant Three [Member]
Class of Stock [Line Items]
Warrant exercise price per share																												$ 0.08
Warrant expire																												Mar. 08, 2023
Purchase Agreement [Member] | Investor [Member]
Class of Stock [Line Items]
Stock issued during period shares new issues																												14,797,278
Share price																												$ 0.06758
Proceeds from issuance of common stock																												$ 1,000,000
Purchase Agreement [Member] | Investor [Member] | 6 Cent Warrants [Member]
Class of Stock [Line Items]
Stock issued during period shares issuance of common stock																												14,797,278
Warrant exercise price per share																												$ 0.06
Purchase Agreement [Member] | Investor [Member] | 8 Cent Warrant [Member]
Class of Stock [Line Items]
Stock issued during period shares issuance of common stock																												7,398,639
Warrant exercise price per share																												$ 0.08
Purchase Agreement [Member] | Investor [Member] | Common Class A [Member]
Class of Stock [Line Items]
Stock issued during period shares new issues																												14,797,278

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)

12 Months Ended

Feb. 16, 2023 shares

Feb. 15, 2022 USD ($) shares

Apr. 16, 2021 USD ($)

Sep. 05, 2019 USD ($) ft²

Aug. 15, 2019 USD ($)

Jul. 03, 2019 USD ($) $ / shares shares

Apr. 26, 2019 USD ($)

Mar. 01, 2019 USD ($) shares

Jan. 01, 2019

Jan. 14, 2016 USD ($) $ / shares shares

Jan. 20, 2015 USD ($) $ / shares shares

Oct. 28, 2011 USD ($) shares

Nov. 10, 2010 USD ($)

Dec. 26, 2006 USD ($)

May 08, 2006 USD ($)

Dec. 31, 2023 USD ($)

Dec. 31, 2022 USD ($) $ / shares

Dec. 31, 2017 USD ($)

Dec. 31, 2016 USD ($)

Dec. 31, 2015 USD ($)

Dec. 31, 2021 USD ($)

Jul. 01, 2021 USD ($) m²

Aug. 08, 2019 $ / shares shares

May 09, 2019 USD ($) m²

Sep. 13, 2017 USD ($)

May 28, 2015 $ / shares shares

Loss Contingencies [Line Items]

Annual salary

$ 797,406

$ 779,742

Accrued salary balance

3,511,776

3,077,393

Number of shares issued | shares

2,434,211

7,398,639

Payment for debt

60,000

60,000

Stock issued during period, value

$ 443,918

Accrued Interest payable

$ 31,657

Area of Land | ft²

5,000

Annual rent, year one

$ 42,000

54,144

$ 39,200

Annual rent, year two

$ 44,800

44,344

$ 42,000

Socialist Republic of Vietnam [Member]

Loss Contingencies [Line Items]

Lessee, Operating Lease, Term of Contract

5 years

Area of Land | m²

6,000

4,560.57

Annual rent, year one

$ 8,645

$ 45,150

Annual rent, year two

$ 45,150

Maximum [Member]

Loss Contingencies [Line Items]

Warrant exercise price per share | $ / shares

$ 0.08

Employment Agreement [Member] | Chief Executive Officer [Member]

Loss Contingencies [Line Items]

Agreement term

5 years

5 years

5 years

5 years

Annual salary

$ 210,000

447,915

$ 315,764

$ 297,889

$ 281,027

Annual salary rate, increase

6%

Employment Agreement [Member] | Employee [Member]

Loss Contingencies [Line Items]

Employee bonus rate

20%

Employment Agreement [Member] | Mr. Jonathan R. Rice [Member]

Loss Contingencies [Line Items]

Annual salary

$ 20,000

$ 20,000

Annual cash compensation

$ 140,000

$ 120,000

Educational expenses

$ 11,000

Warrants term

3 years

5 years

3 years

Warrant to purchase common stock shares | shares

6,000,000

2,000,000

6,000,000

3,000,000

Warrant exercise price per share | $ / shares

$ 0.001

$ 0.001

$ 0.2299

$ 0.001

Warrants maturity date

May 20, 2026

May 28, 2022

Warrants issued value

$ 121,448

One-time bonus

$ 20,000

Payroll payment

3,482

$ 3,728

Employment Agreement [Member] | Mr. Kenneth Le [Member]

Loss Contingencies [Line Items]

Accrued salary balance

1,154

1,243

Annual cash compensation

$ 60,000

Warrants term

3 years

Warrant to purchase common stock shares | shares

2,000,000

Warrant exercise price per share | $ / shares

$ 0.2299

License Agreement [Member]

Loss Contingencies [Line Items]

Agreement term

20 months

License fee

$ 10,000

License maintenance fee

10,000

Annual research fee

13,700

Number of shares issued | shares

2,200,000

Royalty percentage

2%

Termination agreement description

The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $5,000 if the termination takes place within 2 years after its effectiveness, $10,000 if the termination takes place within 4 years after its effectiveness and $20,000 if the Agreement is terminated after 4 years.

License termination fee

$ 5,000

Payment for debt

60,000

License Agreement [Member] | Common Class A [Member]

Loss Contingencies [Line Items]

Number of shares issued | shares

4,025,652

Payment for debt

$ 265,244

Stock issued during period, value

$ 281,659

License Agreement [Member] | Maximum [Member]

Loss Contingencies [Line Items]

Patent maintenance and prosecution related to license cost

$ 10,000

Intellectual Property Transfer Agreement [Member] | Kim Thompson [Member]

Loss Contingencies [Line Items]

Payment for debt

$ 120,000

Outstanding balance

65,292

$ 65,292

Accrued Interest payable

1,960

Operating Lease Agreements [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 42,000

2,508

Operating lease term, description

the Company signed a new two-year lease for this 5,000 square foot property in Lansing, MI that commenced on October 1, 2019 and ended on September 30, 2021, for its research and development headquarters.

Operating Lease Agreements [Member] | October 1, 2022 through September 30, 2023 [Member]

Loss Contingencies [Line Items]

Payments for rent

44,800

Operating Lease Agreements [Member] | October 1, 2023 through September 30, 2024 [Member]

Loss Contingencies [Line Items]

Payments for rent

44,800

Operating Lease Agreements [Member] | October 1, 2024 through September 30, 2025 [Member]

Loss Contingencies [Line Items]

Payments for rent

$ 47,600

SCHEDULE OF ACCOUNTS PAYABLE AN

SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES RELATED PARTY (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Accrued interest - related party			$ 31,657
Related Party [Member]
Related Party Transaction [Line Items]
Accounts payable - related party	388,001	356,191
Accrued expenses - related party	3,516,411	3,082,363
Accrued interest - related party	2,680,236	2,276,454
Total accounts payable and accrued expenses - related party	$ 6,584,648	$ 5,715,008

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jan. 26, 2022	Dec. 31, 2021	Dec. 01, 2020
Related Party Transaction [Line Items]
Paid-in-kind interest	$ 80,851	$ 80,849
Accured interest payable	56,050	54,755
Interest payable	246,714	107,882
Accrued interest related party				$ 31,657
Deposits paid		$ 98,480
Ownership interest percentage		15%
Deposits	95,872
Remaining deposits	0
Related Party [Member]
Related Party Transaction [Line Items]
Notes payable, related parties, current	1,617,000	$ 1,617,000	$ 40,000
Accounts payable related party	388,001	356,191
Accrued expenses related party	3,516,411	3,082,363
Accrued interest related party	2,680,236	2,276,454
Accounts payable and accrued expenses	6,584,648	5,715,008
Royalty agreement payable - related party	65,292	65,292
Senior Staff [Member]
Related Party Transaction [Line Items]
Accrued expenses related party	$ 3,516,411	$ 3,082,363
Chief Executive Officer [Member] | Related Party [Member]
Related Party Transaction [Line Items]
Notes payable, related parties, current					$ 1,657,000
Loans received bear interest					3%

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative)	Mar. 26, 2024 USD ($)	Jan. 31, 2024 USD ($) ft²	Feb. 15, 2022 USD ($)	Feb. 02, 2024 USD ($)	Dec. 31, 2023 USD ($)	Sep. 05, 2019 USD ($) ft²	Sep. 13, 2017 USD ($)
Subsequent Event [Line Items]
Lessee, Operating Lease, Renewal Term						2 years
Area of Land | ft²						5,000
Lessee, Operating Lease, Liability, to be Paid, Year Two					$ 44,344	$ 44,800	$ 42,000
Stock issued during period, value, new issues			$ 443,918
Subsequent Event [Member]
Subsequent Event [Line Items]
Lessee, Operating Lease, Renewal Term		5 years
Area of Land | ft²		700
Lessee, Operating Lease, Liability, to be Paid, Year Two		$ 7,284
Lessee, Operating Lease, Description		For years 3-5 the price will increase with Vietnam’s state land price bracket, not to exceed 10%.
Subsequent Event [Member] | Chief Executive Officer [Member]
Subsequent Event [Line Items]
Accrued expense				$ 90,000
Subsequent Event [Member] | Mr Kim Thompson [Member] | Series A Preferred Stock [Member]
Subsequent Event [Line Items]
Stock issued during period, value, new issues	$ 20,000